Back
Nevro 10K Form
Sell
35
NVRO
Nevro
Last Price:
4.13
Seasonality Move:
7.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | NVRO/Nevro Quarterly |
| 2023-08-01 | 10Q | NVRO/Nevro Quarterly |
| 2023-04-26 | 10Q | NVRO/Nevro Quarterly |
| 2022-11-02 | 10Q | NVRO/Nevro Quarterly |
| 2022-08-03 | 10Q | NVRO/Nevro Quarterly |
| 2022-05-04 | 10Q | NVRO/Nevro Quarterly |
Receive NVRO News And Ratings
See the #1 stock for the next 7 days that we like better than NVRO
NVRO Financial Statistics
Sales & Book Value
| Annual Sales: | $425.17M |
|---|---|
| Cash Flow: | $161K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.31 |
| Price / Book: | 0.58 |
Profitability
| EPS (TTM): | -1.89000 |
|---|---|
| Net Income (TTM): | $-69.31M |
| Gross Margin: | $290.06M |
| Return on Equity: | -24.66% |
| Return on Assets: | -11.58% |
Nevro Earnings Forecast
Key Nevro Financial Ratios
- The Gross Profit Margin over the past 12 years for NVRO is 68.22%.
- The Selling, General & Administrative Expenses for NVRO have been equal to 78.72% of Gross Profit Margin.
- The Research & Development expenses have been 12.80% of Revenue.
- The Interest Expense is -8.69% of Operating Income.
- The Net Earning history of NVRO is -21.69% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 5 years.
Nevro Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NVRO |
| CUSIP: | 64157F |
| Website: | nevro.com |
Debt
| Debt-to-Equity Ratio: | 0.81 |
|---|---|
| Current Ratio: | 5.02 |
| Quick Ratio: | 3.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |